Eye tracking could help virtual reality pain therapy adapt to individual needs

A groundbreaking study from the University of East Anglia explores how artificial intelligence (AI) and eye tracking in virtual reality could revolutionize personalized therapy for chronic pain sufferers. The research, published in the journal Scientific Reports, reveals that subtle changes in pupil size and blinking patterns can indicate the brain's level of mental effort during VR tasks.

By analyzing these signals, AI models achieved up to 88% accuracy in distinguishing between low and high levels of cognitive load in healthy volunteers.

The study, led by Dr. Jordan Tsigarides as part of his Ph.D., involved 84 volunteers, including 42 individuals with chronic musculoskeletal pain conditions such as arthritis and fibromyalgia. Participants engaged in increasingly demanding memory challenges while wearing a VR headset equipped with eye-tracking technology. The findings suggest that future VR systems could automatically adapt therapy in real-time based on the individual's brain activity, optimizing the therapeutic experience while minimizing discomfort and motion sickness.

Chronic pain affects an estimated 1.5 billion people worldwide, ranking as one of the leading causes of disability. Virtual reality has significant therapeutic potential, offering immersive environments that captivate the brain's attention, alleviate stress and anxiety, and potentially retrain the brain's response to pain. However, most VR programs offer a one-size-fits-all approach, failing to account for individual variations in pain and mental effort.

The researchers believe that AI-powered eye-tracking could enable adaptive VR therapies tailored to each patient's unique needs, enhancing the effectiveness of pain management treatments. While the study demonstrated promising results in healthy volunteers, accuracy in individuals with chronic pain was significantly lower. The researchers acknowledge the need for individually calibrated systems and larger studies to validate the potential benefits of adaptive VR therapy for real-world patient outcomes.